Clinical Trial Update: A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of BL0020 injection for small cell lung cancer transformed from non-small cell lung cancer after EGFR TKI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• BL0020

Snippet

Sponsor: Shanghai Best-Link Bioscience, LLC | Conditions: Small Cell Carcinoma of Lung | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING